The Global Renal Dialysis Equipment Market expected to register a CAGR of 9.8% over the forecast period.
As per Johns Hopkins University stated that some people with COVID-19 are showing signs of kidney damage, even those who had no underlying kidney problems before they were infected with the coronavirus. Moreover, about 30% of patients hospitalized with COVID-19 in New York and China developed moderate or severe kidney injury. In patients with COVID-19, signs of kidney problems include abnormal blood work and high levels of protein in the urine which may lead to kidney damage in some cases and equire dialysis.
In addition, as per National Kidney Foundation Inc., in 2020, stated that people who are on dialysis treatment may be at higher risk for severe disease from COVID-19. For severe cases, patient recovery may take 6 weeks or more. Further, about 1% of patient who infected will die from the disease.
Some of the factors which are driving the market growth include primarily attributed to the rise in a number of end-stage renal disease patients (ESRD), growing demand for peritoneal dialysis, rise in cost-effective and accurate portable dialysis apparatus and advanced technologies.
In addition, renal dialysis equipment market is expected to show good growth due to the expanding number of dialysis centres, growth in R&D expenditure for the development of new dialysis products and increasing end-stage renal diseases. In January 2019, Baxter International Inc., received US FDA approval for its clinical trial on on-demand peritoneal dialysis solution generation system. The new system offfers a good platform for patients to perform dialsysis at home.
Globally, there has been increasing incidence of renal diseases, such as the kidney diseases in both the developed and developing countries. Dialysis is thus referred to patients with end-stage renal disorder (ESRD) or chronic kidney diseases.
According to a 2018 study conducted by the University of California San Francisco, an estimated 2 million people in the world suffered from end-stage renal disorders (ESRD).
In addition, according to a research study by Jennifer A Hirst et al., published in British Journal of General Practice 2020, the study results found that about 44.0% of people in United Kingdom with chronic kidney disease (CKD) were undiagnosed without screening, and prevalence of chronic kidney disease (CKD) stages 1-5 was 18.2% in patients aged above 60 years. Therefore increasing burden of disease it is expected to boost the market growth over the forecast period. However, factors such as complications and risks associated with dialysis and reimbursement issues may impede the market growth over the forecast period.
Key Market Trends
Hemodialysis (HD) Equipment is Expected to Hold Significant Market Share During the Forecast Period
Globally, hemodialysis equipment adoption is steadily increasing due to the increasing prevalence of kidney failure patients. It is used to filter wastes and water from the blood. Therefore market players are found focussing on the developments of the new hemodialysis equipment that helps in the growth of the overall market.
COVID-19 is a very high transmission infectious disease with a variable prognosis in the general population. Patients in hemodialysis therapy are vulnerable to developing an infectious disease. Moreover, COVID-19 is a very high transmission disease, and risk factors such as age, hypertension, diabetes, cancer, and chronic respiratory and cardiovascular disease are associated with the worst prognosis. For instance, according to a research article by Claudia Benedetti et al., published in Frontiers in Medicine Journal 2020, the study results indicate that patients with kidney disease could represent a risk factor in elderly patients, for a more severe disease course. COVID-19 infects the kidneys and may induce acute kidney injury.
Furthermore, a research article by Meritxell Ibernon et al., published in Hemodialysis International Journal 2020, found that COVID-19 has shown a high incidence and mortality rate in hemodialysis patients. Thus, early preventive measures against COVID-19 could decrease the risk of spreading disease in vulnerable patients.
Some of the factors which are driving the segment growth include rising prevalence of kidney diseases such as end-stage renal disease (ESRD) along with increasing innovative product launches in the market by market players.
According to the Australian Institute of Health and Welfare National Mortality Database, in 2018, chronic kidney disease contributed about 11% of all deaths (around 16,800 deaths) in Australia. Chronic kidney disease was the underlying cause of death in around 3,600 deaths (21% of CKD deaths).
Furthermore, technological advancements in healthcare are leading to the development of hemodialysis machines with improved ergonomics. For instance, In 2019, Fresenius Medical Care launched 4008A an advanced hemodialysis machine in India market. The newly launched machine is equipped with new blood filtration technology. Thus, owing to above mentioned factors it is expected to drive segment growth over the forcast period.
North America is Expected to Dominate the Renal Dialysis Equipment Market Over the Forecast Period
The factors which are driving the market growth in the North America region include the massive adoption of new technologies in the kidney dialysis division. Adding to that, there is also a boom in public healthcare expenditure and an increase in awareness programs about the availability of advanced treatments.
The novel coronavirus disease 2019 (COVID-19), has a high mortality rate among older adults and individuals suffering from chronic diseases, such as chronic kidney diseases (CKD). As per the Centers for Disease Control and Prevention (CDC) 2019, in the United States, about 15% of adults suffer from chronic kidney diseases (CKD).
Furthermore, in the United States, patients with pre-existing chronic kidney disease (CKD) were considered to be largely susceptible to COVID-19. For instance, a research article by Jennifer E Flythe et al, published in the American Journal of Kidney Diseases 2020, stated that high mortality can be observed in patients with underlying kidney disease and severe COVID-19.
According to a research article by Pietro Ravani et al., published in JAMA Journal 2020, the study results found that incidence rate of stage IV chronic kidney disease increased with advancing age. For those aged 75 years and older, the risk of death was much higher than the risk of kidney failure. High burden of chronic kidney disease is expected to boost the market as this will increase demand for renal dialysis in coming years.
Some of the market players involved in the United States market include DaVita, Baxter International, Medtronic, U.S. Renal Care and among others. These players adopted various strategies such as collaborations, mergers, acquisitions and product innovation to maintain their market position. For instance, in March 2017, the United States Renal Care announced expansion of its dialysis clinic in Dallas. This expansion allowed the company to broaden its business operations and increase customer base.
Thus, owing to above mentioned factors it is expected to drive the market growth over the forcast period.
The Renal Dialysis Equipment market is fragmented competitive and consists of several market players. Some of the market players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market.Some of the market players include Fresenius Kabi AG, B. Braun Melsungen AG, Baxter International, Inc., Nikkiso Co, Ltd. and Nipro Corporation.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
- 1.1 Study Assumptions
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Growing Demand for Peritoneal Dialysis
- 4.2.2 Growth in R&D Expenditure for the Development of New Dialysis Products
- 4.2.3 Increasing Prevalence of Kidney Disease
- 4.3 Market Restraints
- 4.3.1 Complications and Risks Associated With Dialysis
- 4.3.2 Reimbursement Issues
- 4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
- 5.1 By Product Type
- 5.1.1 Hemodialysis (HD) Equipment
- 5.1.2 Peritoneal Dialysis (PD) Equipment
- 5.1.3 Concentrates & Solutions
- 5.1.4 Catheters & Tubings
- 5.1.5 Other Products
- 5.2 By Application
- 5.2.1 Hemodialysis
- 5.2.2 Peritoneal Dialysis
- 5.3 By End User
- 5.3.1 In-Center Dialysis Settings
- 5.3.2 Home Care Settings
- 5.4 Geography
- 5.4.1 North America
- 220.127.116.11 United States
- 18.104.22.168 Canada
- 22.214.171.124 Mexico
- 5.4.2 Europe
- 126.96.36.199 Germany
- 188.8.131.52 United Kingdom
- 184.108.40.206 France
- 220.127.116.11 Italy
- 18.104.22.168 Spain
- 22.214.171.124 Rest of Europe
- 5.4.3 Asia-Pacific
- 126.96.36.199 China
- 188.8.131.52 Japan
- 184.108.40.206 India
- 220.127.116.11 Australia
- 18.104.22.168 South Korea
- 22.214.171.124 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 126.96.36.199 GCC
- 188.8.131.52 South Africa
- 184.108.40.206 Rest of Middle East and Africa
- 5.4.5 South America
- 220.127.116.11 Brazil
- 18.104.22.168 Argentina
- 22.214.171.124 Rest of South America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 Fresenius Kabi AG
- 6.1.2 Baxter International, Inc.
- 6.1.3 Nipro Corporation
- 6.1.4 B. Braun Melsungen AG
- 6.1.5 Nikkiso Co, Ltd.
- 6.1.6 Asahi Kasei Corporation
- 6.1.7 Medtronic PLC
- 6.1.8 Rockwell Medical
- 6.1.9 Teleflex Incorporated
- 6.1.10 Allmed Medical Care Holdings Limited
- 6.1.11 Medivators Inc
- 6.1.12 Toray Medical Co., Ltd.
- 6.1.13 Hemoclean Co., Ltd
- 6.1.14 Medtronic Plc
- 6.1.15 Quanta
- 6.1.16 Outset Medical, Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS